Investor Presentation via Investor Meet Company
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, will announce its audited preliminary results for year ended 31st December 2023 (“FY23”) on 30th April 2024.
Alastair Smith, Chief Executive Officer; Tony Gardiner, Chief Financial Officer; and Christina Coughlin MD, PhD, Head of Research and Development, will also deliver a live presentation via Investor Meet Company at 12:30 BST on the day.
The presentation is open to all existing and potential shareholders.
Investors can sign up to Investor Meet Company for free and add to meet AVACTA GROUP PLC via:
https://www.investormeetcompany.com/avacta-group-plc/register-investor. Investors who already follow Avacta on the Investor Meet Company platform will automatically be invited.
Questions can be submitted pre-event via the Investor Meet Company dashboard up until 29th April 09:00 BST, or at any time during the live presentation.
The Company will also post the results presentation on its website at the following page: https://avacta.com/investors/documents-presentations.